Literatur 1. RKI – Tuberkulose – Bericht zur Epidemiologie der Tuberkulose in Deutschland 2018.
2. Podbielski A, Abele-Horn M, Becker K, Kniehl E, Mauch H et al. MIQ 05: Tuberkulose Mykobakteriose: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Elsevier Health Sciences; 2019.
3. Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W et al. Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP). Pneumologie. Juni 2017; 71(6):325–97.
4. WHO consolidated guidelines on drug-resistant tuberculosis treatment [Internet]. Geneva: World Health Organization; 2019 [zitiert 26. Februar 2020]. WHO Guidelines Approved by the Guidelines Review Committee. Verfügbar unter: www.ncbi.nlm.nih.gov/books/NBK539517/
5. Walker TM, Merker M, Kohl TA, Crook DW, Niemann S, Peto TEA. Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing. Clin Microbiol Infect. März 2017; 23(3):161–6.
6. World Health. The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. 2018 [zitiert 31. März 2020]; Report No.: WHO/CDS/TB/2018.19. Verfügbar unter: apps.who.int/iris/handle/10665/274443
7. Kohl TA, Harmsen D, Rothgänger J, Walker T, Diel R, Niemann S. Harmonized Genome Wide Typing of Tubercle Bacilli Using a Web-Based Gene-By-Gene Nomenclature System. EBioMedicine. August 2018; 34:131–8.
8. Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C et al. Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. Lancet Infect Dis. 2018; 18(6):675–83.
